Tuesday, October 21, 2008
Olmesartan may reduce coronary artery plaque
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque - ScienceDaily
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment